Clinical presentation and surgical quality in treatment of ductal carcinoma in situ of the breast

References

• The concensus conference committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997;80:1798–802.
   PubMedGoogle Scholar
• Gupta SK, Douglas-Jones AG, Fenn N, Morgan JM, Mansel RE. The clinical behaviour of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer 1997; 80: 1740–5
   PubMed Web of Science ®Google Scholar
• Burnstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. New Engl J Med 2004; 350: 1430–41
   PubMedGoogle Scholar
• Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinome of the breast. JAMA 1996; 275: 913–8
   PubMed Web of Science ®Google Scholar
• Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI. Concensus conference on the treatment of in situ ductal carcinoma of the breast, April 22–25, 1999. Cancer 2000; 15: 946–54
   Google Scholar
• Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995; 31A: 1425–7
   PubMedGoogle Scholar
• Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch MD, Fisher ER, et al. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233–41
   PubMed Web of Science ®Google Scholar
• Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004; 96: 443–8
   PubMedGoogle Scholar
• Morrow M, Strom EA, Bassett LW, Dershaw D, Fowble B, Harris JR, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 2002; 52: 256–76
   PubMed Web of Science ®Google Scholar
• Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197–210
   PubMed Web of Science ®Google Scholar
• Page DL, Dupont WD, Rogers WL, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15–25 years after diagnosis of low grade ductal carcinoma in situ of the breast treated only with biopsy. Cancer 1995; 76: 1197–200
   PubMed Web of Science ®Google Scholar
• Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, et al. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Cancer 2001; 91: 1090–7
   PubMedGoogle Scholar
• Ernster V, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 2000; 160: 953–8
   PubMedGoogle Scholar
• Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003; 186: 337–43
   PubMedGoogle Scholar
• Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328: 1581–6
   PubMed Web of Science ®Google Scholar
• Fisher B, Dignam J, Wolmark N, Manounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16: 441–52
   PubMed Web of Science ®Google Scholar
• Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight year update of protocol B-17. Cancer 1999; 86: 429–38
   PubMed Web of Science ®Google Scholar
• Julien J-P, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853. Lancet 2000; 355: 528–33
   PubMed Web of Science ®Google Scholar
• Bijker N, Peterse JL, Duchateau L, Julien J-P, Fentiman IS, Duval C, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 22: 63–71
   Google Scholar
• Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky WS, Colburn WJ, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77: 2267–74
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, et al. The infuence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999; 340: 1455–61
   PubMed Web of Science ®Google Scholar
• Vicini FA, Goldstein NS, Kestin LL. Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy. Ann Oncol 1999; 10: 883–90
   PubMedGoogle Scholar
• Waldman F, DeVries S, Chew KL, Moore DH, Kerlikowske K, Ljung B-M. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 2000; 92: 313–20
   PubMedGoogle Scholar
• Fracheboud J, Otto SJ, Van Dijck JAAM. Decreased rated of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 2004; 91: 861–7
   PubMedGoogle Scholar
• Cataliotti L, Distante V, Ciatto S, Bianchi S, Pacini P, Simoncini R, et al. Intraductal breast cancer: Review of 183 consecutive cases. Eur J Cancer 1992; 28A: 917–20
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Gierson ED, Colburn WJ, Morin Cope L, Furmanski M, Senofsky GM, et al. Can intraductal breast carcinoma be excised completely by local excision?. Cancer 1994; 73: 2985–9
   PubMed Web of Science ®Google Scholar
• Chan KC, Knox WF, Sinha G, Gandhi A, Barr L, Baildam AD, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 2001; 91: 9–16
   PubMed Web of Science ®Google Scholar
• Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519–22
   PubMed Web of Science ®Google Scholar
• Faverly DRG, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications. Semin Diagn Pathol 1994; 11: 193–8
   PubMed Web of Science ®Google Scholar
• Mai KT, Yazdi HM, Burn BF, Perkins DG. Pattern of distribution of intraductal and infiltrating carcinoma: A three-dimensional study using serial coronal giant sections of the breast. Hum Pathol 2000; 31: 464–74
   PubMedGoogle Scholar
• Thomson JZ, Evans AJ, Pinder SE, Burrell HC, Wilson ARM, Ellis IO. Growth pattern of ductal carcinoma in situ (DCIS): A retrospective analysis based on mammographic findings. Br J Cancer 2001; 85: 225–7
   PubMed Web of Science ®Google Scholar
• Jha MK, Avlonitis VS, Griffith CDM, Lennard TWJ, Wilson RG, McLean LM, et al. Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence. Eur J Surg Oncol 2001; 27: 545–58
   PubMedGoogle Scholar
• Vicini FA, Kestin LL, Goldstein NS, Baglan KL, Pattinga JE, Martinez AA. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Surg Oncol 2001; 76: 245–54
   PubMedGoogle Scholar
• Goldstein NS, Kestin L, Vicini F. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. Am J Surg Pathol 1999; 23: 1340–8
   PubMedGoogle Scholar
• Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992; 10: 356–63
   PubMed Web of Science ®Google Scholar